BlackRock Investment Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$5.01M Sell
90,841
-886
-1% -$48.6K 0.01% 1595
2016
Q3
$5.18M Buy
91,727
+1,026
+1% +$50.3K 0.01% 1458
2016
Q2
$3.79M Buy
90,701
+21,616
+31% +$996K ﹤0.01% 1630
2016
Q1
$2.95M Buy
69,085
+2,329
+3% +$98.4K ﹤0.01% 1738
2015
Q4
$3.02M Buy
66,756
+202
+0.3% +$8.49K ﹤0.01% 1773
2015
Q3
$2.58M Sell
66,554
-1,065
-2% -$42.6K ﹤0.01% 1878
2015
Q2
$2.46M Buy
67,619
+13,233
+24% +$419K ﹤0.01% 2064
2015
Q1
$1.57M Buy
54,386
+1,105
+2% +$30.8K ﹤0.01% 2203
2014
Q4
$1.29M Buy
+53,281
New +$1.2M ﹤0.01% 2371

Other funds holding PRAH

BlackRock Investment Management's PRAH Position: Q4 2016 in Review

BlackRock Investment Management reduced its PRA Health Sciences, Inc. (PRAH) stake by 0.97% in Q4 2016, selling an estimated $48.6K and leaving 90,841 shares worth $5.01M. The position accounts for 0.01% of the portfolio, ranked #1595.

BlackRock Investment Management first reported a position in PRAH in Q4 2014 and has held it in 9 quarters since. The position peaked at $5.18M in Q3 2016. 189 funds tracked by Wall St. Rank hold PRAH as of Q4 2016.

  • BlackRock Investment Management held 90,841 shares of PRA Health Sciences, Inc. worth $5.01M as of Q4 2016.
  • BlackRock Investment Management sold 886 PRA Health Sciences, Inc. shares in Q4 2016, an estimated $48.6K.
  • PRA Health Sciences, Inc. made up 0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1595 holding.
  • BlackRock Investment Management first reported a position in PRA Health Sciences, Inc. in Q4 2014 and has held it in 9 quarters since.
  • BlackRock Investment Management's PRA Health Sciences, Inc. position peaked at $5.18M in Q3 2016.
  • 189 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.